Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.29 USD | +0.35% | +37.10% | -24.75% |
May. 09 | Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup | DJ |
May. 09 | Transcript : Embecta Corp., Q2 2024 Earnings Call, May 09, 2024 |
Chart calendar Embecta Corp.
Upcoming events on Embecta Corp.
Past events on Embecta Corp.
2024-05-09 08:00 am | Q2 2024 Earnings Call |
2024-05-09 06:30 am | Q2 2024 Earnings Release |
2024-03-05 | Non Deal Roadshow - Wolfe Research |
2024-02-12 | Investor Meeting |
2024-02-09 08:00 am | Q1 2024 Earnings Call |
2024-02-09 05:30 am | Q1 2024 Earnings Release |
2024-02-07 08:00 am | Annual General Meeting |
2024-01-10 05:15 pm | JPMorgan Healthcare Conference |
2023-12-11 12:30 pm | MedTech Madness West Coast Bus Tour Conference |
2023-12-05 | Mizuho Medical Device and Healthcare Services Summit |
2023-11-21 07:00 am | Q4 2023 Earnings Call |
2023-11-21 05:30 am | Q4 2023 Earnings Release |
2023-09-12 02:55 pm | Morgan Stanley Global Healthcare Conference |
2023-08-08 08:00 am | Q3 2023 Earnings Call |
2023-08-08 06:30 am | Q3 2023 Earnings Release |
2023-06-21 | JMP Securities MedTech Forum |
2023-06-08 03:30 pm | Jefferies Global Healthcare Conference |
2023-05-16 03:05 pm | RBC Capital Markets Global Healthcare Conference |
2023-05-12 08:00 am | Q2 2023 Earnings Call |
2023-05-12 05:30 am | Q2 2023 Earnings Release |
Past dividends on Embecta Corp.
2024-02-26 | Quarterly 0.15 USD |
2023-11-30 | Quarterly 0.15 USD |
2023-08-23 | Quarterly 0.15 USD |
2023-05-24 | Quarterly 0.15 USD |
2023-02-23 | Quarterly 0.15 USD |
2022-12-28 | Quarterly 0.15 USD |
2022-08-24 | Quarterly 0.15 USD |
Annual results
Fiscal Period | September | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1 165 | 1 130 1 117 1.13% | 1 121 1 112 0.81% | 1 115 |
EBITDA Million USD | Released Forecast Spread | 0,00 | 460 428 7.47% | 379 371 1.95% | 341 |
EBIT Million USD | Released Forecast Spread | 0,00 | 310 379 -18.39% | 222 327 -32.33% | 285 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 257 316 -18.85% | 106 217 -51.24% | 168 |
Net income Million USD | Released Forecast Spread | 415 | 224 275 -18.81% | 70,4 105 -33.27% | 70,8 |
EPS USD | Released Forecast Spread | 0,00 | 3,89 4,43 -12.09% | 1,22 1,31 -6.87% | 1,22 |
Announcement Date | 21/12/21 | 20/12/22 | 21/11/23 | - |
Quarterly results
Fiscal Period | September | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 291 277 5.14% | 275 261 5.2% | 276 263 4.87% | 277 263 5.41% | 286 275 4.01% | 282 272 3.81% | 277 265 4.68% | 287 265 8.51% | 268 | 282 | 278 | 281 | 282 |
EBITDA Million USD | Released Forecast Spread | 118 89,8 31.24% | 87,2 84,1 3.67% | 110 77,9 41.48% | 96,7 78,2 23.63% | 92,2 77,1 19.61% | 79,6 72,8 9.29% | 90,4 78,0 15.84% | 90,8 71,8 26.39% | 77,9 | 84,9 | 86,3 | 87,9 | 85,0 |
EBIT Million USD | Released Forecast Spread | 97,1 83,1 16.8% | -3,00 69,4 -104.33% | 102 67,4 50.65% | 84,9 67,2 26.4% | 51,3 66,0 -22.31% | 25,8 59,7 -56.76% | 77,5 63,4 22.29% | 74,9 56,6 32.42% | 63,1 | 68,6 | 67,8 | 69,0 | 67,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -27,5 32,1 -185.67% | 56,1 38,1 47.24% | 24,5 34,4 -28.78% | 20,1 36,5 -44.93% | 5,00 28,8 -82.64% | 14,3 33,1 -56.8% | 43,0 | 42,0 | |||||
Net income Million USD | Released Forecast Spread | 62,4 50,1 24.48% | -17,2 34,6 -149.73% | 35,2 28,7 22.68% | 14,0 25,8 -45.74% | 15,2 27,4 -44.53% | 6,00 10,8 -44.19% | 20,1 16,4 22.56% | 28,9 4,30 572.09% | 12,0 | 13,8 | 22,6 | 23,1 | 23,4 |
EPS USD | Released Forecast Spread | 1,07 0,87 22.99% | -0,30 0,59 -150.85% | 0,61 0,50 22% | 0,24 0,50 -51.52% | 0,26 0,47 -44.68% | 0,10 0,19 -47.37% | 0,35 0,29 20.69% | 0,50 0,07 614.29% | 0,21 | 0,24 | 0,38 | 0,39 | 0,40 |
Announcement Date | 15/08/22 | 20/12/22 | 14/02/23 | 12/05/23 | 08/08/23 | 21/11/23 | 09/02/24 | 09/05/24 | - | - | - | - | - |
2024-05-13 | HLB CO., LTD.: Q1 2024 Earnings Release (Projected) |
2024-05-13 | TERUMO CORPORATION: Q4 2023 Earnings Release |
2024-05-13 | ALFRESA HOLDINGS CORPORATION: Q4 2023 Earnings Release |
2024-05-14 01:00 am | AMBU A/S: Q2 2024 Earnings Release |
2024-05-14 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | HOYA CORPORATION: Q4 2023 Earnings Release |
2024-05-16 02:00 am | CONVATEC GROUP PLC: Q1 2024 Sales and Revenue Release - Trading Update |
2024-05-22 01:00 am | YPSOMED HOLDING AG: Q4 2024 Earnings Release |
2024-05-23 06:45 am | MEDTRONIC PLC: Q4 2024 Earnings Release |
2024-05-24 08:00 am | MESA LABORATORIES, INC.: Q4 2024 Earnings Release |
Past sector events for Embecta Corp.
Today | PARAMOUNT BED HOLDINGS CO., LTD.: Q4 2023 Earnings Release |
2024-05-10 04:10 pm | ATRION CORPORATION: Q1 2024 Earnings Release |
2024-05-09 | NIPRO CORPORATION: Q4 2023 Earnings Release |
2024-05-09 | PHC HOLDINGS CORPORATION: Q4 2023 Earnings Release |
2024-05-09 04:30 pm | METTLER-TOLEDO INTERNATIONAL, INC.: Q1 2024 Earnings Release |
2024-05-09 04:03 pm | BIOLIFE SOLUTIONS, INC.: Q1 2024 Earnings Release |
2024-05-09 04:01 pm | INSULET CORPORATION: Q1 2024 Earnings Release |
2024-05-09 06:30 am | STEVANATO GROUP S.P.A.: Q1 2024 Earnings Release |
2024-05-09 06:30 am | EMBECTA CORP.: Q2 2024 Earnings Release |
2024-05-09 06:00 am | HAEMONETICS CORPORATION: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EMBC Stock
- Calendar Embecta Corp.